A detailed history of Vela Investment Management, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Vela Investment Management, LLC holds 15,635 shares of DNLI stock, worth $429,493. This represents 0.14% of its overall portfolio holdings.

Number of Shares
15,635
Holding current value
$429,493
% of portfolio
0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$20.96 - $31.05 $327,709 - $485,466
15,635 New
15,635 $455,000
Q4 2023

Jan 30, 2024

BUY
$16.2 - $23.18 $101,185 - $144,782
6,246 Added 31.39%
26,145 $561,000
Q3 2023

Nov 07, 2023

SELL
$20.63 - $30.17 $15,946 - $23,321
-773 Reduced 3.74%
19,899 $410,000
Q1 2023

May 08, 2023

BUY
$21.91 - $32.67 $151,748 - $226,272
6,926 Added 50.39%
20,672 $476,000
Q4 2022

Jan 31, 2023

BUY
$26.28 - $33.92 $128,903 - $166,377
4,905 Added 55.48%
13,746 $382,000
Q3 2022

Nov 10, 2022

BUY
$25.97 - $38.53 $229,600 - $340,643
8,841 New
8,841 $271,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.69B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Vela Investment Management, LLC Portfolio

Follow Vela Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vela Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vela Investment Management, LLC with notifications on news.